Cargando…

Copeptin and stress-induced hyperglycemia in critically ill patients: A prospective study

OBJECTIVES: Copeptin, an equimolar indicator of serum antidiuretic hormone levels, has been associated with higher mortality in critically ill patients and with the development of diabetes in the general population. The aim of the present study was to investigate the association of copeptin levels w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henrique, Lilian Rodrigues, Crispim, Daisy, Vieceli, Tarsila, Schaeffer, Ariell Freires, Bellaver, Priscila, Leitão, Cristiane Bauermann, Rech, Tatiana Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059855/ https://www.ncbi.nlm.nih.gov/pubmed/33882083 http://dx.doi.org/10.1371/journal.pone.0250035

Ejemplares similares

Diabetes associates with mortality in critically ill patients with SARS-CoV-2 pneumonia: No diabetes paradox in COVID-19
por: Bellaver, Priscila, et al.
Publicado: (2023)

Association of multiple glycemic parameters at intensive care unit admission with mortality and clinical outcomes in critically ill patients
por: Bellaver, Priscila, et al.
Publicado: (2019)

Brain death-induced cytokine release is not associated with primary graft dysfunction: a cohort study
por: Rech, Tatiana Helena, et al.
Publicado: (2019)

Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 Genes Are Associated with Worse Clinical Outcomes in COVID-19
por: Dieter, Cristine, et al.
Publicado: (2022)

Pancreatic size and fat content in diabetes: A systematic review and meta-analysis of imaging studies
por: Garcia, Tiago Severo, et al.
Publicado: (2017)

Brain Death-Induced Inflammatory Activity is Similar to Sepsis-Induced Cytokine Release
por: Schwarz, Patrícia, et al.
Publicado: (2018)

Copeptin Predicts Mortality in Critically Ill Patients
por: Krychtiuk, Konstantin A., et al.
Publicado: (2017)

Genetic polymorphisms associated with susceptibility to COVID-19 disease and severity: A systematic review and meta-analysis
por: Dieter, Cristine, et al.
Publicado: (2022)

Copeptin and acute renal failure in critically ill patients
por: Meyer, B, et al.
Publicado: (2008)

Comparison of two techniques for evaluation of pancreatic islet viability: flow cytometry and FDA/PI staining
por: Lemos, Natália Emerim, et al.
Publicado: (2015)

Elevated Extracellular HSP72 and Blunted Heat Shock Response in Severe COVID-19 Patients
por: Borges Russo, Mariana Kras, et al.
Publicado: (2022)

Copeptin as a marker of shock and predictor of adverse outcome in critically ill patients
por: Meyer, B, et al.
Publicado: (2008)

Incidence of venous thromboembolism among patients with severe COVID-19 requiring mechanical ventilation compared to other causes of respiratory failure: a prospective cohort study
por: Pellegrini, José Augusto Santos, et al.
Publicado: (2021)

Assessment and treatment of hyperglycemia in critically ill patients
por: Viana, Marina Verçoza, et al.
Publicado: (2014)

Hyperglycemia in critically ill children
por: Patki, Vinayak Krishnarao, et al.
Publicado: (2014)

Copeptin Release in Arterial Hypotension and Its Association with Severity of Disease in Critically Ill Children
por: Baumann, Philipp, et al.
Publicado: (2022)

Nitric oxide system and diabetic nephropathy
por: Dellamea, Bruno Schmidt, et al.
Publicado: (2014)

Laughter as medicine: A systematic review and meta-analysis of interventional studies evaluating the impact of spontaneous laughter on cortisol levels
por: Kramer, Caroline Kaercher, et al.
Publicado: (2023)

Copeptin in anorexia nervosa
por: Goetze, Jens P., et al.
Publicado: (2020)

Hyperglycemia in Critically Ill Patients: Management and Prognosis
por: Godinjak, Amina, et al.
Publicado: (2015)

Evaluation and treatment of hyperglycemia in critically ill patients
por: Balloni, Andrea, et al.
Publicado: (2016)

Copeptin in aneurysmal subarachnoid hemorrhage
por: Tamargo, Rafael J
Publicado: (2012)

Copeptin under glucagon stimulation
por: Lewandowski, Krzysztof C., et al.
Publicado: (2015)

Arginine Vasopressin and Copeptin in Perinatology
por: Evers, Katrina Suzanne, et al.
Publicado: (2016)

Copeptin analysis in endocrine disorders
por: Moodley, Nareshni
Publicado: (2023)

Copeptin Implementation on Stroke Prognosis
por: Karatzetzou, Stella, et al.
Publicado: (2023)

Hyperglycemia and acute kidney injury in critically ill children
por: Gordillo, Roberto, et al.
Publicado: (2016)

Hyperglycemia in Acute Critically Ill COVID-19 Patients
por: Cilloniz, Catia, et al.
Publicado: (2023)

Ventilator-associated events: From surveillance to optimizing management
por: Ramirez-Estrada, Sergio, et al.
Publicado: (2022)

Central hemodynamic parameters to predict cardiovascular outcomes and mortality among the elderly: protocol for a systematic review
por: Sausen, Grasiele, et al.
Publicado: (2018)

Bedside echocardiography in critically ill patients
por: Casaroto, Eduardo, et al.
Publicado: (2015)

High Salt Intake Increases Copeptin but Salt Sensitivity Is Associated with Fluid Induced Reduction of Copeptin in Women
por: Tasevska, Irina, et al.
Publicado: (2014)

Risk stratification in emergency patients by copeptin
por: Iversen, Kasper, et al.
Publicado: (2014)

Copeptin—Marker of Acute Myocardial Infarction
por: Möckel, Martin, et al.
Publicado: (2014)

Serum copeptin and pregnancy outcome in preeclampsia
por: Akinlade, Kehinde Sola, et al.
Publicado: (2015)

Pathophysiology of copeptin in kidney disease and hypertension
por: Afsar, Baris
Publicado: (2017)

Copeptin as a marker of atherosclerosis and arteriosclerosis
por: Schill, Fredrika, et al.
Publicado: (2021)

Copeptin in Patients with Pregnancy-Induced Hypertension
por: Marek, Agnieszka, et al.
Publicado: (2021)

Approach to the Patient: “Utility of the Copeptin Assay”
por: Christ-Crain, Mirjam, et al.
Publicado: (2022)

Copeptin in Growth Hormone-Treated Patients
por: Sjöström, Anna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8fnsdfp4oi7si2uk5q17d564gl